The Next-Generation Nicotine Vaccine: A Novel and Potent Hybrid Nanoparticle-Based Nicotine Vaccine

Biomaterials - United Kingdom
doi 10.1016/j.biomaterials.2016.08.028
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Enhanced Immunogenicity of a Bivalent Nicotine Vaccine

International Immunopharmacology
AllergyImmunologyPharmacology
2008English

Innate Immunity and Next-Generation Vaccine

Drug Delivery System
Pharmaceutical Science
2012English

Next Generation Immunology: The Quest for a Universal Vaccine

Prescriber
Pharmacology
2017English

Hybrid Alphavirus-Rhabdovirus Propagating Replicon Particles Are Versatile and Potent Vaccine Vectors

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2008English

Genetic Diversity of the Pneumococcal CbpA: Implications for Next-Generation Vaccine Development

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Tuberculosis Vaccine Development :The Development of a Novel (Preclinical) DNA Vaccine

Human Vaccines
2010English

The MIC3 Gene of Toxoplasma Gondii Is a Novel Potent Vaccine Candidate Against Toxoplasmosis

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2003English

Next Generation Hybrid Nanofiber Based Electrochromic Devices

Academic Perspective Procedia
2018English

Randomised Trial Investigating Effect of a Novel Nicotine Delivery Device (Eclipse) and a Nicotine Oral Inhaler on Smoking Behaviour, Nicotine and Carbon Monoxide Exposure, and Motivation to Quit

Tobacco Control
EnvironmentalPublic HealthHealthOccupational Health
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy